(Q44754347)

6 December 2017

A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China (English)

1 reference

6 December 2017

0 references

1 reference

S Deng

1

1 reference

6 December 2017

H Hu

2

1 reference

6 December 2017

P Abliz

3

1 reference

6 December 2017

Z Wan

4

1 reference

6 December 2017

A Wang

5

1 reference

6 December 2017

W Cheng

6

1 reference

6 December 2017

R Li

7

1 reference

6 December 2017

language of work or name

1 reference

24 June 2011

1 reference

6 December 2017

8

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

6 December 2017

172

1 reference

6 December 2017

5

1 reference

6 December 2017

365-372

1 reference

https://scigraph.springernature.com/pub.10.1007/s11046-011-9438-2

6 December 2017

0 references

cites work

Changes in frequency of agents of tinea capitis in school children from Western China suggest slow migration rates in dermatophytes

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Tinea capitis: a treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Terbinafine pulse therapy is effective in tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

In vitro susceptibility of dermatophytes to antifungal drugs: a comparison of two methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9438-2

Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin

21 January 2018

1 reference

12 December 2020

Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo

1 reference

12 December 2020

A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis

1 reference

12 December 2020

Griseofulvin and terbinafine in the treatment of tinea capitis in children.

1 reference

12 December 2020

A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis

1 reference

12 December 2020

10.1007/S11046-011-9438-2

Identifiers

DOI

1 reference

6 December 2017

1 reference